<DOC>
	<DOCNO>NCT03064451</DOCNO>
	<brief_summary>The primary purpose study ass effectiveness use CARTOFINDER™ map create RHYTHMFINDER-192 catheter CARTOFINDER™ Algorithm terminate persistent atrial fibrillation ( PsAF ) either Normal Sinus Rhythm Atrial Tachycardia compare pulmonary vein isolation ( PVI ) treat PsAF . The RHYTHMFINDER-192 catheter investigational , CARTOFINDER™ system CE mark Europe . All subject persistent AF schedule undergo clinically indicated ablation procedure management persistent AF target population screening . The study enroll approximately 40-70 subject . Subjects undergo CARTOFINDER™ guide ablation ( CFGA ) follow PVI . Subjects follow-up visit 7 day , 3 , 6 12 month postprocedure .</brief_summary>
	<brief_title>Repetitive Activation Patterns Focal Impulses Identification Ablation Persistent AF</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>1 . Age &gt; 18 year . 2 . Patients sign Patient Informed Consent Form ( ICF ) 3 . Scheduled undergo clinicallyindicated catheter ablation procedure treatment 1. persistent atrial fibrillation ( define continuous atrial fibrillation sustain beyond seven consecutive day ) . 2. drugresistant atrial fibrillation . ( fail 1 class I III antiarrhythmic drug ) demonstrate Persistent AF ( require drug electrical shock terminate AF ) 4 . In AF time baseline CARTOFINDER™ Map ( spontaneous ) 5 . Left Atrium ( LA ) must demonstrate sufficient electrical activity allow identification ablation target . 6 . Able willing comply pre , post , followup testing requirement ( e.g . patient confined court ruling ) 1 . Paroxysmal Atrial Fibrillation 2 . Continuous AF &gt; 12 month ( 1Year ) ( Longstanding Persistent AF ) Subjects previously diagnose Long Standing Persistent ( LSP ) demonstrate ability maintain Normal Sinus Rhythm &gt; 30 day cardioversion AF great 1 year time procedure remain eligible inclusion . 3 . Previous ablation procedure PsAF ( define ablation involve PV isolation ) 4 . Patients leave atrial size &gt; 55 mm ( echocardiography , parasternal long axis view ) . 5 . Inability restore sinus rhythm 30 second longer opinion investigator . 6 . Significant congenital anomaly medical problem opinion investigator would preclude enrollment study . 7 . Atrial arrhythmia patient structural atrial disease prior history atriotomy prior atrial surgery , presence atrial septal defect , and/or presence atrial septal closure patch . 8 . History current blood clot bleed abnormality , contraindication systemic anticoagulation ( i.e. , heparin , warfarin , dabigatran , direct thrombin inhibitor ) . 9. significant pulmonary disease , cardiac surgery , unstable angina , uncontrolled heart failure , acute illness systemic infection , disease malfunction would preclude treatment opinion investigator . 10 . Current enrollment study evaluate another device drug . 11 . A complex arrhythmia secondary electrolyte imbalance , thyroid disease , reversible noncardiac cause . 12 . Any cardiac surgery within past 60 day ( 2 month ) ( include PCI ) 13 . Subjects ever undergo valvular cardiac surgical procedure ( i.e. , ventriculotomy , atriotomy , valve repair replacement presence prosthetic valve ) 14 . Prior ICD pacemaker implant 15 . Presence intramural thrombus , tumor abnormality precludes catheter introduction manipulation . 16 . Presence condition precludes vascular access . 17 . Subject contraindication device study per IFU 18 . Women child bear potential pregnant , lactate , plan become pregnant course trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>persistent atrial fibrillation - ablation procedure</keyword>
</DOC>